Tai-Tsung Corp. March 2026 Revenue NT$62 million (YoY +9.1%)

Tai-Tsung's monthly revenue for March 2026 was NT$62 million, an increase of 9.1% year-over-year. The company is classified in the biotechnology and medical care industry.
生技醫療業NQ 7/100出典:PR Times

📋 Article Processing Timeline

  • 📰 Published: March 1, 2026 at 09:00
  • 🔍 Collected: April 12, 2026 at 16:30 (1015h 30m after Published)
  • 🤖 AI Analyzed: April 12, 2026 at 21:27 (4h 57m after Collected)
Tai-Tsung Corp. (Stock Code: 4169), a player in the Biotechnology and Medical Care industry, has announced its March 2026 revenue. The company posted a monthly revenue of 61,779 thousand NTD (approximately NT$62 million), achieving a significant year-over-year growth of 9.1%.